Wearing off, dyskinesia, and the use of continuous drug delivery in parkinson's disease

19Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Motor fluctuations (wearing off) and motor complications (dyskinesia) are common features of the long-term treatment of Parkinson's disease (PD). The basis of both is considered to be a reflection of the progression of neuronal degeneration, coupled with the nature of drug treatment used to control motor symptoms. The concept of continuous dopaminergic stimulation has been used to explain both the onset of wearing off and dyskinesia and their avoidance through pharmacologic manipulation. This review focuses on using with the transdermal dopamine agonist, rotigotine, for continuous dopaminergic drug delivery in the treatment of PD. © 2013 Elsevier Inc.

Cite

CITATION STYLE

APA

Jenner, P. (2013, August). Wearing off, dyskinesia, and the use of continuous drug delivery in parkinson’s disease. Neurologic Clinics. https://doi.org/10.1016/j.ncl.2013.04.010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free